Cas 920270-45-7,3-(4'-octyl-biphenyl-4-yl)-3-oxo-2-(triphenyl-λ5-phosphanylidene)-propionitrile

920270-45-7

Post Buying Request

Basic information

Product Name: 3-(4'-octyl-biphenyl-4-yl)-3-oxo-2-(triphenyl-λ5-phosphanylidene)-propionitrile
Synonyms: 3-(4'-octyl-biphenyl-4-yl)-3-oxo-2-(triphenyl-λ5-phosphanylidene)-propionitrile
CAS NO:920270-45-7
Molecular Formula:
Molecular Weight: 593.748
EINECS: N/A
Product Categories: N/A
Mol File: 920270-45-7.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(4'-octyl-biphenyl-4-yl)-3-oxo-2-(triphenyl-λ5-phosphanylidene)-propionitrile(CAS DataBase Reference)
NIST Chemistry Reference: 3-(4'-octyl-biphenyl-4-yl)-3-oxo-2-(triphenyl-λ5-phosphanylidene)-propionitrile(920270-45-7)
EPA Substance Registry System: 3-(4'-octyl-biphenyl-4-yl)-3-oxo-2-(triphenyl-λ5-phosphanylidene)-propionitrile(920270-45-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 920270-45-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

920270-45-7 Suppliers

Recommended suppliersmore

920270-45-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 920270-45-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,0,2,7 and 0 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 920270-45:
(8*9)+(7*2)+(6*0)+(5*2)+(4*7)+(3*0)+(2*4)+(1*5)=137
137 % 10 = 7
So 920270-45-7 is a valid CAS Registry Number.

920270-45-7Upstream product

59662-49-6 4-n-octylbiphenyl-4'-carboxylic acid

920270-45-7Downstream Products

920270-45-7Relevant articles and documents

COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS

-

Page/Page column 69, (2008/06/13)

Disclosed herein are novel compounds with activity at RARβ 2 receptors. Further disclosed are the use of such compounds for treatment of or to alleviate symptoms of cancer, neurological disorders such as memory deficits and schizophrenia, neurodegenerative disorders such as Parkinson's and Alzheimer's diseases, inflammatory disorders such as psoriasis and rheumatoid arthritis, eye disorders and depression.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 920270-45-7